These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 24122861)
21. Recombinant heat shock protein 70 functional peptide and alpha-fetoprotein epitope peptide vaccine elicits specific anti-tumor immunity. Wang XP; Wang QX; Lin HP; Xu B; Zhao Q; Chen K Oncotarget; 2016 Nov; 7(44):71274-71284. PubMed ID: 27713135 [TBL] [Abstract][Full Text] [Related]
22. Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer. Butterfield LH; Ribas A; Potter DM; Economou JS Cancer Immunol Immunother; 2007 Dec; 56(12):1931-43. PubMed ID: 17522860 [TBL] [Abstract][Full Text] [Related]
23. Association Between High-Avidity T-Cell Receptors, Induced by α-Fetoprotein-Derived Peptides, and Anti-Tumor Effects in Patients With Hepatocellular Carcinoma. Nakagawa H; Mizukoshi E; Kobayashi E; Tamai T; Hamana H; Ozawa T; Kishi H; Kitahara M; Yamashita T; Arai K; Terashima T; Iida N; Fushimi K; Muraguchi A; Kaneko S Gastroenterology; 2017 May; 152(6):1395-1406.e10. PubMed ID: 28188748 [TBL] [Abstract][Full Text] [Related]
24. Antitumor immunity induced by DNA vaccine encoding alpha-fetoprotein/heat shock protein 70. Wang XP; Liu GZ; Song AL; Li HY; Liu Y World J Gastroenterol; 2004 Nov; 10(21):3197-200. PubMed ID: 15457574 [TBL] [Abstract][Full Text] [Related]
25. Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patients. Alisa A; Ives A; Pathan AA; Navarrete CV; Williams R; Bertoletti A; Behboudi S Clin Cancer Res; 2005 Sep; 11(18):6686-94. PubMed ID: 16166448 [TBL] [Abstract][Full Text] [Related]
26. Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma. Chen Y; Yang D; Li S; Gao Y; Jiang R; Deng L; Frankel FR; Sun B Oncogene; 2012 Apr; 31(17):2140-52. PubMed ID: 21927025 [TBL] [Abstract][Full Text] [Related]
27. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells. Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295 [TBL] [Abstract][Full Text] [Related]
28. Personalized neoantigen vaccine combined with PD-1 blockade increases CD8 Chen H; Li Z; Qiu L; Dong X; Chen G; Shi Y; Cai L; Liu W; Ye H; Zhou Y; Ouyang J; Cai Z; Liu X J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36113894 [TBL] [Abstract][Full Text] [Related]
29. Glycoprotein 96 and α-fetoprotein cross-linking complexes elicited specific antitumor immunity. Wang XP; Wang QX; Lin HP; Wang YL; Yang Y Cancer Biother Radiopharm; 2013 Jun; 28(5):406-14. PubMed ID: 23484810 [TBL] [Abstract][Full Text] [Related]
30. AFP-specific CD4+ helper T-cell responses in healthy donors and HCC patients. Evdokimova VN; Liu Y; Potter DM; Butterfield LH J Immunother; 2007; 30(4):425-37. PubMed ID: 17457217 [TBL] [Abstract][Full Text] [Related]
31. Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells. González-Carmona MA; Märten A; Hoffmann P; Schneider C; Sievers E; Schmidt-Wolf IG; Sauerbruch T; Caselmann WH Liver Int; 2006 Apr; 26(3):369-79. PubMed ID: 16584401 [TBL] [Abstract][Full Text] [Related]
32. Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses. Zuo B; Zhang Y; Zhao K; Wu L; Qi H; Yang R; Gao X; Geng M; Wu Y; Jing R; Zhou Q; Seow Y; Yin H J Hematol Oncol; 2022 Apr; 15(1):46. PubMed ID: 35488312 [TBL] [Abstract][Full Text] [Related]
33. Identification of alpha-fetoprotein-derived peptides recognized by cytotoxic T lymphocytes in HLA-A24+ patients with hepatocellular carcinoma. Mizukoshi E; Nakamoto Y; Tsuji H; Yamashita T; Kaneko S Int J Cancer; 2006 Mar; 118(5):1194-204. PubMed ID: 16152611 [TBL] [Abstract][Full Text] [Related]
34. Chen K; Wu Z; Zhao H; Wang Y; Ge Y; Wang D; Li Z; An C; Liu Y; Wang F; Bi X; Wang H; Cai J; Ma C; Qu C Cancer Immunol Res; 2020 Jan; 8(1):81-93. PubMed ID: 31666238 [TBL] [Abstract][Full Text] [Related]
35. Status of and prospects for cancer vaccines against hepatocellular carcinoma in clinical trials. Sun Z; Zhu Y; Xia J; Sawakami T; Kokudo N; Zhang N Biosci Trends; 2016 May; 10(2):85-91. PubMed ID: 26522694 [TBL] [Abstract][Full Text] [Related]
36. Induction of alpha-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells. Zhang HM; Zhang LW; Ren J; Fan L; Si XM; Liu WC Cell Immunol; 2006 Feb; 239(2):144-50. PubMed ID: 16814271 [TBL] [Abstract][Full Text] [Related]
37. Lentivector prime and vaccinia virus vector boost generate high-quality CD8 memory T cells and prevent autochthonous mouse melanoma. Xiao H; Peng Y; Hong Y; Liu Y; Guo ZS; Bartlett DL; Fu N; He Y J Immunol; 2011 Aug; 187(4):1788-96. PubMed ID: 21746967 [TBL] [Abstract][Full Text] [Related]
38. Anti-tumor efficacy of a hepatocellular carcinoma vaccine based on dendritic cells combined with tumor-derived autophagosomes in murine models. Su S; Zhou H; Xue M; Liu JY; Ding L; Cao M; Zhou ZX; Hu HM; Wang LX Asian Pac J Cancer Prev; 2013; 14(5):3109-16. PubMed ID: 23803088 [TBL] [Abstract][Full Text] [Related]
39. Lentivector immunization stimulates potent CD8 T cell responses against melanoma self-antigen tyrosinase-related protein 1 and generates antitumor immunity in mice. Liu Y; Peng Y; Mi M; Guevara-Patino J; Munn DH; Fu N; He Y J Immunol; 2009 May; 182(10):5960-9. PubMed ID: 19414747 [TBL] [Abstract][Full Text] [Related]
40. Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity. Wang X; Wang Q Can J Gastroenterol Hepatol; 2018; 2018():9049252. PubMed ID: 29805966 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]